Catalyst Brief

← Calendar

Readoutin 14d

Chia Tai Tianqing Pharmaceutical Group Co., Ltd. — TQB3616 capsules, Letrozole, Anastrozole, Tamoxifen

Phase 3 primary completion: Clinical Study on Adjuvant Therapy of TQB3616 Combined With Endocrine Therapy Compared With Placebo Combined With Endocrine Therapy in Patients With Breast Cancer.

Date
Dec 2026
Type
Readout
Indication
Breast Cancer

Source ↗Add to calendar

Get told when this date moves

The weekly brief is free. Pro adds reminders 7 days and 1 day before.

More from Chia Tai Tianqing Pharmaceutical Group Co., Ltd.

  1. Jan2027
  2. Dec2026